Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Ptc Therapeutics (PTCT-Q) from The Globe and Mail including charting and trades.

Sanofi's Tzield is now the first and only disease-modifying therapy to be approved for type 1 diabetes (T1D) in the UK.

It's the second time this year the stock has slumped significantly in one day, and it might represent another attractive ...

And one of the best ways to cash in on that is to invest in stocks that can exceed the market's performance. Two that look ...

Vertex Pharmaceuticals shows promising signs despite a recent price drop. Strong fundamentals underscore its market position, ...

A joint venture led by locally based REIT Diversified Healthcare Trust (NASDAQ: DHC) has received $1 billion for the refinancing of the Vertex Pharmaceuticals headquarters facility in Boston. A ...

Vertex Pharmaceuticals Incorporated has been a hot topic lately, but it's crucial to dig into the details before investing.

The RMR Group secured a $1 billion refinancing for Vertex Pharmaceuticals' Boston Seaport headquarters, a five-year, interest ...

The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) reported Q2 CY2025 results beating Wall Street’s revenue expectations, ...

Vertex Pharmaceuticals’ second quarter 2025 results exceeded Wall Street’s expectations, but the market responded sharply ...